From: Registries for orphan drugs: generating evidence or marketing tools?
Approval type | Subtotal | Registry not part of approval | Registry part of approval |
---|---|---|---|
Conditional approval | 9 | 1 (11,1%) | 8 (88,9%) |
Exceptional circumstances | 16 | 0 (0%) | 16 (100%) |
No conditional approval or exceptional circumstances | 63 | 32 (50,8%) | 31 (49,2%) |
Total | 88 | 33 (37,5%) | 55 (62,5%) |